AMDF and TLI launch a campaign to raise awareness about macular degeneration with the official release of a short film featuring TLI fellow Laura Carabello.
New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease. The University of Bristol-led research is published in Cardiovascular Diabetology.
A 2024 AMD Awareness Month Resource Page, designed for the public and journalists, offers educational content, shareable talking points, fact sheets, shareable social media graphics, videos, opportunities for action, and more.
As executive vice president from 1993 to 2009, Dr. Hoskins grew the American Academy of Ophthalmology into the world’s largest association of eye physicians and surgeons and guided it into the digital era, with the goal of providing ophthalmologists worldwide with resources to improve ophthalmic care and their patients’ lives.
Working with mammalian retinal cells, neuroscientists at Johns Hopkins Medicine have shown that, unlike most light-sensing cells (photoreceptors) in the retina, one special type uses two different pathways at the same time to transmit electrical “vision” signals to the brain.
Alyssa L. Lie, PhD, BOptom (University of Auckland, New Zealand) and Tarsis Gesteira Ferreira, MSc, PhD (University of Houston, Texas) have been named the inaugural recipients of the ARVO Foundation Research Catalyst Awards.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Neil Lagali, PhD (Linköping University, Sweden) and Mehrdad Rafat, PhD (LinkoCare Life Sciences AB /NaturaLens AB, Sweden) — recipients of the 2023 Point of View Award.
Metalens-array-based integral imaging (Meta-II) display is promising for next-generation true-3D near-eye displays (NEDs) by addressing various long-standing issues in conventional optical architecture through the tremendous flexibility in light manipulation (https://doi.org/10.1186/s43593-023-00055-1).
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the recipients of the 2023 ARVO Foundation Collaborative Research Fellowship: Marianna Hollaender, MD; Rodrigo Riedel, PhD; Paula Tenconi, PhD.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today that Glenn Yiu, MD, PhD, has won the 2024 Carl Camras Translational Research Award.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the 2024 recipients of the Dr. David L. Epstein Award: Yvonne Ou, MD (mentor) and Tyson Kim, MD, PhD.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates David Zacks, MD, PhD — 2023 recipient of the Kreissig Award for Excellence in Retinal Surgery.
A team at NYU Tandon School of Engineering will kick off the second phase of an ambitious research project that aims to transform navigation and accessibility for many of the 285 million people with blindness and low vision (pBLV) worldwide.
Researchers at the National Eye Institute (NEI) have improved a crucial step in the production of retinal pigment epithelium (RPE), a tissue they grow in the lab from patient blood cells and are testing in a clinical trial as treatment for age-related macular degeneration (AMD).
Glaucoma effects around 70 million people worldwide and can cause irreversible loss of vision if not treated – but around half of those living with the condition are not aware of it.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Elizabeth Rossin, MD, PhD — 2024 recipient of the Bert M. Glaser, MD Award for Innovative Research in Retina. The award recognizes an early-career investigator who has discovered a novel drug, technique, or the understanding of a mechanism of disease that impacts the understanding and/or treatment of a retinal disease or condition.
Attracting nearly 400 participants annually, this unique gathering unites leaders in the field of glaucoma for a full day of informative presentations, stimulating discussions, and valuable networking opportunities.
The Glaucoma 360 Annual Gala will include a reception, a silent art auction featuring artists with vision impairment, and a dinner to celebrate the donors, volunteers, and scientists who do so much to advance Glaucoma Research Foundation’s mission to cure glaucoma and restore vision through innovative research.
Since 2021 The Glaucoma Foundation (sponsored by Patricia Hill) has been co-funding up to five $10,000 supplemental Fellowships with Research to Prevent Blindness (RPB). The fellowships for 2024, and the winner of the RPB/ TGF Career Advancement Award in Glaucoma have just been announced.
A Johns Hopkins Children’s Center study of children and youth with diabetes concludes that so-called autonomous artificial intelligence (AI) diabetic eye exams significantly increase completion rates of screenings designed to prevent potentially blinding diabetes eye diseases (DED).
The rapid development of infrared technology, especially infrared cameras on UAVs, has expanded the applications of aerial infrared photography in military, industrial, agricultural, and environmental contexts.
Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.
The National Science Foundation (NSF) announced that a team led by Saint Louis University will receive a $5 million award as one of 6 teams chosen to advance to Phase 2 of the Convergence Accelerator Program, Track H: Enhancing Opportunities for Persons with Disabilities.
Dozens of eye drop recalls this year have left consumers confused about product safety. An expert explains why there have been so many recalls and how to pick safe eye drops.
After two years of advocacy from the ophthalmology community, Aetna confirmed in a letter to the American Academy of Ophthalmology last week that it will no longer require pre-approval for cataract surgeries for Medicare Advantage beneficiaries in Georgia, starting Jan.1.
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce a key update to the Company's Lucyd app for Android, the first app to enable a voice interface for ChatGPT.
Advancements in the care of premature babies are leading to improved survival rates. However, the incidence of neonatal diseases with life-long consequences such as bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) is increasing.
With a single flash of light to the eye, artificial intelligence (AI) could deliver a faster and more accurate way to diagnose autism spectrum disorder (ASD) in children, according to new research from the University of South Australia and Flinders University.
Amidst the demand for innovative dry eye solutions, a groundbreaking collaboration between distinguished scientists and healthcare experts has been published in an exceptional white paper revealing the questions surrounding Dry Eye Disease (DED).
The recipient of the Research to Prevent Blindness / David Epstein Career Advancement Award in Glaucoma Research sponsored by Alcon is Alex Huang, MD, PhD, Associate Professor of Ophthalmology at the UC San Diego School of Medicine.
Phoebe Peng, an Engineering Honours student at the University of Sydney, is researching ways to allow people with low vision and blindness to play pingpong using sound. The process uses neuromorphic cameras and an array of loudspeakers, designed to allow players to track the ball and movements based on sound. Using two perfectly positioned cameras, Peng could identify and track a ball in 3D in real time. She then fed that data into an algorithm controlling loudspeakers along the sides of the table, which created a sound field matching the position of the ball.
3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests. The advance could revolutionise monitoring of kidney disease, which often progresses without symptoms in the early stages. Experts say the technology has potential to support early diagnosis as current screening tests cannot detect the condition until half of the kidney function has been lost.
As humans age, our eyes adjust based on how we use them, growing or shortening to focus where needed, and we now know that blurred input to the eye while the eye is growing causes myopia.
Press conferences for Acoustics 2023 Sydney will be held virtually at 8:00 a.m. AEDT, Dec. 6 and Dec. 7. Topics will focus on a wide range of newsworthy sessions from the upcoming meeting, which runs Dec. 4-8 in Sydney, Australia.
Glaucoma is a disease that damages the optic nerve, the cable that connects the eye to the brain. This can lead to blindness. There are currently no symptoms for early glaucoma, but later on patients may experience difficulty seeing in the dark or difficulty reading
Investigators from the Board of Governors Regenerative Medicine Institute at Cedars-Sinai are advancing stem cell technology to treat degenerative diseases of the eye.
Glaucoma remains one of the most common causes of vision loss and blindness in the U.S. and much of the world, disproportionately affecting older people, African Americans, and Hispanics and Latinos.
When's the right time for an older adult to stop driving? Researchers at the University of Western Australia sought to shed light on this question by investigating at what point declining vision increases the risk of a car accident.
Compelling evidence accumulated over the last 20 years, conducted primarily in East Asia, suggests that an eye drop, low-dose atropine, can significantly slow the progression of myopia. However, a U.S.-based study published this year showed mixed results, underscoring the need for more research on myopia and atropine.